BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 16050418)

  • 1. Short term experience with "modern" trabeculectomy augmented with intraoperative antimetabolites.
    Detry-Morel M; Pourjavan S
    Bull Soc Belge Ophtalmol; 2005; (296):37-48. PubMed ID: 16050418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative safety profile between "modern" trabeculectomy and non-penetrationg deep sclerectomy.
    Detry-Morel M; Pourjavan S; Detry MB
    Bull Soc Belge Ophtalmol; 2006; (300):43-54. PubMed ID: 16903511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed post-operative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Zuppardi E; Lobefalo L; Gallenga PE
    Eye (Lond); 1998; 12 ( Pt 4)():701-6. PubMed ID: 9850268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study.
    Vijaya L; Mukhesh BN; Shantha B; Ramalingam S; Sathi Devi AV
    Ophthalmic Surg Lasers; 2000; 31(1):24-30. PubMed ID: 10976557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.
    Smith MF; Doyle JW; Nguyen QH; Sherwood MB
    J Glaucoma; 1997 Apr; 6(2):104-10. PubMed ID: 9098818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up.
    Sisto D; Vetrugno M; Trabucco T; Cantatore F; Ruggeri G; Sborgia C
    Acta Ophthalmol Scand; 2007 May; 85(3):267-71. PubMed ID: 17488455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimetabolites in glaucoma surgery--long-term results].
    Michalíková L; Ferková S; Jakabovicová E; Strmen P
    Cesk Slov Oftalmol; 2002 May; 58(3):180-6. PubMed ID: 12087664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of "low dose" 5-fluorouracil during trabeculectomy].
    Detry-Morel M; Kolanowski C
    Bull Soc Belge Ophtalmol; 1999; 272():33-42. PubMed ID: 10427918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
    Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
    Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needling revision of trabeculectomies bleb morphology and long-term survival.
    Rotchford AP; King AJ
    Ophthalmology; 2008 Jul; 115(7):1148-1153.e4. PubMed ID: 18082890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [5-fluorouracil in the treatment of postoperative glaucoma].
    Kuljaca Z; Jojić Z
    Srp Arh Celok Lek; 1996; 124(7-8):190-2. PubMed ID: 9102845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
    Belyea DA; Dan JA; Lieberman MF; Stamper RL
    J Glaucoma; 1997 Apr; 6(2):90-8. PubMed ID: 9098816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non penetrating deep sclerectomy (NPDS) with SKGEL implant and/or 5-fluorouracile (5-FU).
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2001; (280):23-32. PubMed ID: 11486461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
    Anand N; Khan A
    J Glaucoma; 2009 Sep; 18(7):513-20. PubMed ID: 19223788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of nonpenetrating deep sclerectomy with reticulated hyaluronic acid implant SKGEL and/or preoperative application of 5-luorouracil: results of 2 and a half years].
    Detry-Morel M; De Temmerman S
    Bull Soc Belge Ophtalmol; 2003; (287):53-62. PubMed ID: 12784578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of early IOP in mitomycin-C augmented trabeculectomy.
    Alwitry A; Moodie J; Rotchford A; Abedin A; Patel V; King AJ
    J Glaucoma; 2007; 16(7):616-21. PubMed ID: 18091180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery.
    Snir M; Lusky M; Shalev B; Gaton D; Weinberger D
    Ophthalmic Surg Lasers; 2000; 31(1):31-7. PubMed ID: 10976558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trabeculectomy in congenital glaucoma: retrospective medium and long-term results].
    Detry-Morel M; Feron EM
    Bull Soc Belge Ophtalmol; 1996; 262():143-51. PubMed ID: 9376918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for developing avascular filtering bleb after fornix-based trabeculectomy with mitomycin C.
    Hirooka K; Mizote M; Baba T; Takagishi M; Shiraga F
    J Glaucoma; 2009; 18(4):301-4. PubMed ID: 19365195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
    Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
    Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.